Practice
Featured experience
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
Amer Sports $1.3 billion secondary offering
We advised Amer Sports on its SEC-registered secondary offering of ordinary shares
Cintas $5.3 billion proposal to acquire UniFirst
We are advising Cintas on the proposed acquisition
Turn Therapeutics direct listing
We advised Turn Therapeutics on its Nasdaq listing
CoreWeave acquisition of Monolith AI
We are advising CoreWeave on the transaction
Credo Technology $750 million at-the-market offering
We advised Credo on the offering
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
Oruka Therapeutics $200 million at-the-market offering
We advised Oruka on the offering
Emera $750 million fixed-to-fixed reset rate junior subordinated notes offering
We advised Emera on its offering
Arcos Dorados $200 million revolving credit facility
We advised Arcos Dorados on the transaction
Kingsoft Cloud HK$2.8 billion placement of shares
We advised Kingsoft Cloud on its placement of new shares
Bain Capital GSS Investment $460 million SPAC IPO
We advised Bain Capital GSS Investment, a SPAC, on its IPO and NYSE listing
Mirion Technologies concurrent stock and convertible notes offerings
We advised Mirion Technologies on its $425 million stock offering and concurrent $375 million convertible notes offering